T lymphocytes are central components of the adaptive immune system, tasked with recognising and responding to a wide array of antigens. Their activation is initiated through the engagement of the T ...
Lymphocyte activation gene-3 (LAG-3) has emerged as a pivotal immune checkpoint in the regulation of T cell responses within the tumour microenvironment. Structurally related to CD4, LAG-3 binds major ...
The Endoscopic Ultrasound Molecular Analysis of Pancreatic Cancer (EUMEPC) study. This is an ASCO Meeting Abstract from the 2023 ASCO Gastrointestinal Cancers Symposium. This abstract does not include ...
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study Patients with advanced ...
Familial HLH is a success story in modern medicine. Initially a disease that was largely unknown and fatal, it is now understood on a molecular level and is curable. Moreover, HLH is an archetype of ...
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical ...
A high-throughput cytometry workflow consolidates marker expression, proliferation, and cytokine release into a single assay ...
Lymphocytosis means you have a higher-than-usual lymphocyte count, often defined as more than 3 to 4 billion cells per liter of blood. Lymphocytes are white blood cells that help fight disease. Smudge ...